{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:40:24Z","timestamp":1790804424286,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rdc.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T16:37:46Z","timestamp":1432571866000},"page":"459-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Systemic Sclerosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Genevieve","family":"Gyger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.rdc.2015.04.007_bib1","first-page":"iii36","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.007_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002281-199611000-00012","article-title":"Gastrointestinal features of scleroderma","volume":"8","author":"Sjogren","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.04.007_bib4","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","article-title":"Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells","volume":"297","author":"Singh","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.rdc.2015.04.007_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2012.07.109","article-title":"Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function","volume":"143","author":"Singh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2015.04.007_bib6","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/rheumatology\/ket441","article-title":"The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population","volume":"53","author":"Baron","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.007_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22490","article-title":"Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III","volume":"67","author":"Baron","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.007_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/rheumatology\/keu396","article-title":"The Canadian Systemic Sclerosis Oral Health Study II: the relationship between oral and global health-related quality of life in systemic sclerosis","volume":"54","author":"Baron","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.007_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ard.2007.081612","article-title":"Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.04.007_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00296-010-1595-y","article-title":"Early endoscopy in systemic sclerosis without gastrointestinal symptoms","volume":"32","author":"Thonhofer","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2015.04.007_bib11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/rheumatology\/ker110","article-title":"Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study","volume":"50","author":"Wipff","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.007_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2015.04.007_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/BOR.0000000000000117","article-title":"Evaluation and management of gastrointestinal manifestations in scleroderma","volume":"26","author":"Kirby","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib14","first-page":"S15","article-title":"Assessment of gastrointestinal involvement","volume":"21","author":"Clements","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib15","first-page":"S-214","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.02707.x","article-title":"Review article: proton pump inhibitors and bacterial overgrowth","volume":"23","author":"Williams","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rdc.2015.04.007_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1183\/09031936.06.00037005","article-title":"High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis","volume":"27","author":"Raghu","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2015.04.007_bib18","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1164\/ajrccm.158.6.9804105","article-title":"Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis","volume":"158","author":"Tobin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2015.04.007_bib19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3899\/jrheum.120705","article-title":"Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis","volume":"40","author":"Zhang","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.129.3.794","article-title":"Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series","volume":"129","author":"Raghu","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2015.04.007_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000156958","article-title":"Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis","volume":"77","author":"de Souza","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.rdc.2015.04.007_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2125.1991.tb05593.x","article-title":"The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study","volume":"31","author":"Kahan","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rdc.2015.04.007_bib23","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association technical review on the management of Barrett's esophagus","volume":"140","author":"Spechler","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2015.04.007_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/egh.13.22","article-title":"Systemic sclerosis and the gut","volume":"7","author":"Butt","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib25","first-page":"S42","article-title":"Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel","volume":"28","author":"Baron","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib26","first-page":"349","article-title":"The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders","volume":"46","author":"Peeters","year":"1991","journal-title":"Z\u00a0Gesamte Inn Med"},{"key":"10.1016\/j.rdc.2015.04.007_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.121087","article-title":"Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial","volume":"40","author":"Hung","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3899\/jrheum.090600","article-title":"Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors","volume":"37","author":"Ingraham","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000124339","article-title":"Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment","volume":"77","author":"Selinger","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.rdc.2015.04.007_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2015.04.007_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.007_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2004.08.009","article-title":"Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature","volume":"34","author":"Jaovisidha","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.007_bib33","first-page":"323","article-title":"Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study","volume":"40","author":"Soifer","year":"2010","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1016\/j.rdc.2015.04.007_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ajg.2009.91","article-title":"Bacillus clausii as a treatment of small intestinal bacterial overgrowth","volume":"104","author":"Gabrielli","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2015.04.007_bib35","first-page":"S22","article-title":"Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating\/distention","volume":"29","author":"Frech","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib36","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rdc.2015.04.007_bib37","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/01.mcg.0000128925.06662.69","article-title":"Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities","volume":"38","author":"Urdaci","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.rdc.2015.04.007_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/1529-0131(199907)42:7<1545::AID-ANR30>3.0.CO;2-T","article-title":"Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases","volume":"42","author":"Perlemuter","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.007_bib39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","article-title":"Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma","volume":"325","author":"Soudah","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.007_bib40","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1136\/gut.35.3_Suppl.S11","article-title":"Octreotide in gastrointestinal motility disorders","volume":"35","author":"Owyang","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2015.04.007_bib41","first-page":"446","article-title":"Global improvement of systemic scleroderma under long-term administration of octreotide","volume":"9","author":"Descamps","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib42","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/BF02208652","article-title":"Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction","volume":"40","author":"Verne","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rdc.2015.04.007_bib43","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3899\/jrheum.090694","article-title":"Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database","volume":"36","author":"Baron","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib44","first-page":"260","article-title":"Digestive manifestations in systemic sclerosis","volume":"153","author":"Attar","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.rdc.2015.04.007_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1148\/radiology.213.3.r99dc21837","article-title":"The \u201chide-bound\u201d bowel sign","volume":"213","author":"Pickhardt","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.rdc.2015.04.007_bib46","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s10620-010-1229-y","article-title":"Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation","volume":"55","author":"Sloots","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rdc.2015.04.007_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2036.2011.04907.x","article-title":"Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction\u2013a double-blind, placebo-controlled, cross-over, multiple n\u00a0= 1 study","volume":"35","author":"Emmanuel","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rdc.2015.04.007_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1572-0241.2002.05396.x","article-title":"Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride","volume":"97","author":"Boeckxstaens","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2015.04.007_bib49","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/ker153","article-title":"Internal anal sphincter atrophy in patients with systemic sclerosis","volume":"50","author":"Thoua","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.007_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajg.2011.399","article-title":"Fecal incontinence in systemic sclerosis is secondary to neuropathy","volume":"107","author":"Thoua","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2015.04.007_bib51","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.51.6.881","article-title":"Sacral nerve stimulation for faecal incontinence due to systemic sclerosis","volume":"51","author":"Kenefick","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2015.04.007_bib52","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2015.04.007_bib54","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.22910","article-title":"Depression in patients with systemic sclerosis: a systematic review of the evidence","volume":"57","author":"Thombs","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.007_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.23524","article-title":"Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis","volume":"59","author":"Thombs","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.007_bib56","first-page":"51","article-title":"Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis","volume":"32","author":"Nietert","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/rheumatology\/keq296","article-title":"Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis","volume":"50","author":"Bodukam","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.007_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MEG.0b013e32831dac75","article-title":"Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study","volume":"21","author":"Franck-Larsson","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib59","first-page":"1117","article-title":"Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases","volume":"33","author":"Johnson","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.explore.2013.10.001","article-title":"Acupuncture-based modalities: novel alternative approaches in the treatment of gastrointestinal dysmotility in patients with systemic sclerosis","volume":"10","author":"Sallam","year":"2014","journal-title":"Explore (NY)"},{"issue":"Suppl 4","key":"10.1016\/j.rdc.2015.04.007_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jgh.12253","article-title":"Non-nutritional effects of food: an underutilized and understudied therapeutic tool in chronic gastrointestinal diseases","volume":"28","author":"Gibson","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2015.04.007_bib62","first-page":"739","article-title":"Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome","volume":"8","author":"Magge","year":"2012","journal-title":"Gastroenterol Hepatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:47Z","timestamp":1760181227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X15000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0889857X15000289"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}